Tinea capitis in Brooklyn

Area of Science:

• Dermatology
• Mycology
• Pediatrics

Background:

• Tinea capitis is a prevalent pediatric fungal infection across the United States.
• Understanding the causative agents and demographic distribution is crucial for effective management.

Purpose of the Study:

• To analyze the clinical and mycological features of tinea capitis cases.
• To evaluate the efficacy of griseofulvin and other treatments for tinea capitis.

Main Methods:

• A 12-month study of 144 clinically diagnosed tinea capitis cases.
• Fungal cultures were performed to identify causative organisms.
• Treatment outcomes with griseofulvin, erythromycin, topical antifungals, and prednisone were assessed.

Main Results:

• Trichophyton tonsurans (89%) was the predominant pathogen, followed by Microsporum (11%).
• The infection predominantly affected black children aged 4-5 years, with equal gender distribution.
• Griseofulvin achieved mycologic and clinical cure in a mean of 4.7 weeks; prednisone reduced inflammation in kerions.

Conclusions:

• Trichophyton tonsurans is the leading cause of tinea capitis in this pediatric cohort.
• Griseofulvin remains a highly effective treatment for tinea capitis.
• Systemic prednisone can significantly alleviate inflammation associated with kerions.